Search results
Results From The WOW.Com Content Network
The 2024 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.
Pocket Guide for asthma management and prevention for adults and children older than 5 years (updated 2020). Summary for primary health care providers, to be used in conjunction with the main GINA report. Difficult-to-treat and severe asthma in adolescent and adult patients. Diagnosis and Management.
GINA recommends that asthma in adults and adolescents should not be treated solely with short-acting β 2 -agonist (SABA), because of the risks of SABA-only treatment and SABA overuse, and evidence for benefit of inhaled corticosteroids (ICS).
GINA recommends treating patients with mild intermittent asthma with as-needed inhaled corticosteroids (ICS) with short-acting beta 2 agonists (SABAs) for children six to 11 years of age and...
The 2019 Global Initiative for Asthma (GINA) guidelines recommend that all asthma patients be treated with inhaled corticosteroids taken daily or as needed; this improves symptoms and outcomes, even in those with mild disease.
The latest update to the Global Initiative for Asthma (GINA) guidelines includes significant changes to treatment recommendations, especially a recommendation against using a short-acting beta...
Of note, the GINA 2020 guidelines address asthma and COVID-19; they emphasize continuing to take all prescribed asthma medications, having a clearly written asthma action plan, and preferentially using metered-dose inhalers over nebulizers when possible.
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.
The GINA Pocket Guide on Difficult to Treat and Severe Asthma v2.0 2019 provides a decision tree and practical guide for assessment and management in adults and adolescents. Sputum-guided treatment, if available, improves outcomes in moderate-severe asthma.
The Global Initiative for Asthma 2019 guidelines provide recommendations for asthma treatment organized into five steps that correlate with disease severity. Medication options include inhaled corticosteroids (ICS), long-acting beta 2 agonists, short-acting beta 2 agonists (SABAs), leukotriene receptor antagonists, and oral corticosteroids.